Emphasizing the importance of the tumor microenvironment (TME) and reflecting concerns that systemic IL-2 can expand Treg populations, the group went on to demonstrate improved persistence and response rates of >50% with prior depletion of Treg cells using a recombinant IL-2-diptheria toxin protein [119]. Here, IL2 is linked to neoplasm.